Monday, December 15, 2014

Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study.

Women prescribed aspirin after a diagnosis of breast cancer had an almost 50% decreased risk of all-cause mortality, and a greater than 50% decreased risk of breast cancer specific mortality after adjusting for age, socioeconomic status, TNM stage, tumour grade, estrogen receptor status, surgery, radiotherapy, chemotherapy, adjuvant endocrine therapy and aspirin use pre-diagnosis.  (Br J Cancer. 2014 Jul 29;111(3):623-7.)
Read More